Planmed launches improved Planmed Verity CBCT scanner

Article

The scanner is said to offer enhanced image quality and new options for head and neck imaging.

Planmed presents the improved Planmed Verity® CBCT scanner, a unique 3D imaging solution for orthopedic as well as head and neck imaging. The scanner reportedly now offers enhanced image quality, new options for head and neck imaging, the Planmeca Ultra Low Dose™ imaging protocol for lower patient doses, and the Planmeca CALM™ algorithm for motion artefact correction.

New options for head and neck imaging with exceptional image quality

Image quality of the adaptable and mobile Planmed Verity® has reportedly been enhanced to meet all imaging needs. The high-quality images of Planmed Verity are said to visualize even the smallest bone structures with minimal interference. This exceptional image quality combined with new patient and volume positioning options reportedly makes it possible to acquire images of the head and neck region with greater precision than before. Planmed Verity covers ear, nose and throat imaging as well as basic 3D dental imaging needs. 

“We are pleased to further improve Planmed Verity and its maxillofacial and ENT imaging options. This is something our customers have requested and we are happy to answer this need,” says Jan Moed, managing director of Planmed. “This unit is now more versatile than ever before. It is an easy-to-use and cost-efficient solution, making it a great tool for any imaging center, clinic or hospital.”

Related article: Planmeca introduces imaging solution

New algorithm solves the challenge of movement artefacts

The groundbreaking Planmeca CALM™ motion artefact correction is now available for Planmed Verity. The Planmeca CALM algorithm reportedly eliminates the need for retakes by cancelling the effects of patient movement, which makes it excellent for imaging more lively patients. This feature will reportedly not only save time for clinicians but also guard patients from unnecessary doses.

Lower patient doses with the Planmeca Ultra Low Dose™ protocol

The innovative Planmeca Ultra Low Dose (ULD) imaging protocol is now available for the Planmed Verity scanner. Planmeca ULD is engineered to combine clinical image quality with extremely low effective patient doses, enabling 3D imaging with a dose close to standard 2D imaging. The protocol is said to allow reducing the Planmed Verity scanner’s already low effective patient doses by 50 percent without compromising diagnostic image quality. Also, the new volume positioning possibilities reportedly enable enhanced accuracy to the imaging area, reducing the amount of radiation your patients are exposed to.

“New innovative features such as Planmeca CALM and Planmeca ULD are great examples of the fruits of our deep collaboration with our parent company Planmeca," Moed says. "I’m extremely excited to see the heights our unique Planmed Verity scanner can reach within the world of medical imaging."

The new features are now available inside the European Union and other countries in the European Economic Area where CE mark applies.

Recent Videos
DS World 2024 Interview with Dentsply Sirona President and CEO Simon Campion in Las Vegas.
Greg Campbell, DDS, talks about the next generation zirconia blocks from Kuraray at DS World in Las Vegas.
At DS World 24, Max Milz, Dentsply Sirona VP, Connected Technology Solutions, talks about the company's new Primescan 2 intraoral scanning solution and how it fits in with a variety of digital dentistry workflows.
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
The Uptime Health Story: An Interview with Uptime Health CEO and Co-Founder Jinesh Patel
2024 Dental Products Report Spring Selection Bracket Reveal Video
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
Product Bites – March 8, 2024 Part 2
Product Bites – March 8, 2024 Part 1
© 2024 MJH Life Sciences

All rights reserved.